Q1 2026 KP Tissue Inc Earnings Call Transcript

May 14, 2026 / 12:30 PM GMT
Release Date Price: $8.44 (+1.08%)

Key Points

Positve
  • KP Tissue Inc (KPTSF) reported a strong adjusted EBITDA of $86.9 million for Q1 2026, marking a 14.6% year-over-year increase.
  • The company maintained a solid EBITDA margin of 16%, driven by lower pulp prices and reduced warehousing costs.
  • Production rates across all paper machines and converting lines exceeded targets, supporting revenue momentum.
  • The new state-of-the-art converting line in Memphis is expected to add capacity and support premium product focus.
  • KP Tissue Inc (KPTSF) improved its market share in the facial tissue segment to nearly 47% in Canada.
Negative
  • Overall revenue declined slightly by 0.3% year-over-year, impacted by unfavorable foreign exchange rates.
  • Sales in the United States decreased by 1.5%, primarily due to a high comparison base from the previous year.
  • The company faces escalating input costs, including higher fuel and freight expenses.
  • There is category softness in the Canadian market, with a reported 1% decline in units.
  • The proposed TAD facility in the western United States is facing delays, with startup now expected in late 2028.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

KPT.TO - KP Tissue Inc
Q1 2026 KP Tissue Inc Earnings Call
May 14, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome to KPTSU's first quarter 2026 results conference call. Today's call is being recorded for replay.

All participants are currently in listen-only mode.

Following the presentation, we will conduct a question-and-answer session.

Instructions will be provided at the time for you to queue up for questions.

If at any time you have difficulties here in the conference, please press followed by 0 for operator assistance.

I will now turn the call over to Doris Grubik, Director of Investor Relations. You may begin your conference.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-----------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot